NIH-funded research Sbir 2 grant

Long-lasting delivery of Tizanidine to treat severe muscle stiffness

Official title: Sustained Delivery of Tizanidine for Maintenance Treatment of Moderate to Severe Spasticity

Funded at Delpor, INC. · NIH-10490906 · Data updated 2026-11-12

This study is working on a new way to deliver Tizanidine, a medicine that helps with muscle tightness and spasms, to make it easier for people with conditions like cerebral palsy, multiple sclerosis, and spinal cord injuries to manage their symptoms and feel better.

More Spasticity research and trials

Quick facts

Grant typeSbir 2 grant
Study typeNIH-funded research
Funding institutionDelpor, INC.
NIH-funded
Lab location1 site (South San Francisco, United States)
Project startApril 15, 2019
Project endAugust 31, 2025
Funding year2022
Award (this year)$1,246,488
NIH project number5R44NS110135-03
Project IDNIH-10490906 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include adults and children with moderate to severe spasticity due to conditions such as cerebral palsy, multiple sclerosis, or spinal cord injuries.

Less likely to help

Patients who do not experience spasticity or have mild forms of muscle stiffness may not benefit from this research.

What this research studies

This research focuses on developing a method for sustained delivery of Tizanidine, a medication used to treat spasticity, which is characterized by increased muscle tone and involuntary muscle contractions. The approach aims to provide a more consistent and effective treatment for patients suffering from conditions like cerebral palsy, multiple sclerosis, and spinal cord injuries, who often experience inadequate symptom relief with current treatment methods. By reducing the frequency of medication administration and minimizing side effects, this research seeks to improve the quality of life for patients with severe spasticity.

Why it matters

Potential benefit: If successful, this research could significantly enhance the management of spasticity, leading to improved daily functioning and quality of life for affected patients.

How similar studies have gone: Previous research has shown that sustained delivery systems for medications can improve treatment outcomes, indicating potential success for this novel approach.

Where this research is happening

  • Delpor, INC.
    South San Francisco, United States
    Active

Researchers

  • Principal investigator: Watkins, Gregory — Delpor, INC.
  • Study coordinator: Watkins, Gregory

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Browse more
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.